Propranolol in infantile haemangioma: simplifying pretreatment monitoring
BACKGROUND: Infantile haemangiomas (IHs) are very common vascular tumours. Propranolol is at present the first-line treatment for problematic and complicated haemangioma. In accordance with a Swiss protocol, children are monitored for 2 days at the start of the treatment to detect possible side...
Main Authors: | Oumama El Ezzi, Judith Hohlfeld, anthony de Buys Roessingh |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2014-02-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1834 |
Similar Items
-
Variable response to propranolol therapy for infantile hemangiomas
by: Vishesh Jain, et al.
Published: (2012-01-01) -
Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas
by: Ren L, et al.
Published: (2025-02-01) -
Excellent Response of Infantile Hemangioma with Oral Propranolol: A Case Report
by: Armyta Denissafitri, et al.
Published: (2022-11-01) -
Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma
by: Shinichi Ashizawa, et al.
Published: (2024-04-01) -
Deep coma in a child treated with propranolol for infantile hemangioma
by: Ilirjana Bakalli, et al.
Published: (2019-07-01)